FDA Examines Testosterone Use in Menopausal Women
The FDA examined testosterone use in menopausal women, including current evidence, safety questions, research gaps and potential future drug development.
Cendifensine Shows Dramatic Hot Flash Reduction in Phase 2 Trial
Hot flashes are the #1 menopause complaint, yet millions of women can’t — or prefer not to — use hormone therapy.
That’s why the newest data on Cendifensine is getting so much attention.
Black Women’s Health Imperative Releases Landmark Survey on Menopause Experiences
Black women are navigating menopause with less support, more symptoms, and higher rates of medical dismissal — and now we finally have the data to prove it. The Black Women’s Health Imperative has released the largest U.S. survey ever conducted on Black women’s menopause experiences, uncovering major gaps in care, information, and equity. Here’s what the findings reveal — and why this research matters for every woman in midlife.
A Historic Win for Women: FDA Drops Black Box Warning from Menopausal Hormone Therapy
In a historic move, the FDA has requested the removal of the black box warning from hormone therapy used for menopause. Experts say this long-overdue update reflects modern science—and could help women reclaim access to safe, effective symptom relief.
FDA Approves Lynkuet (Elinzanetant): First Non-Hormonal Pill for Menopausal Hot Flashes
The FDA has approved Lynkuet (Elinzanetant), a groundbreaking non-hormonal medication that targets the brain pathways behind hot flashes. For women who can’t or prefer not to use hormone therapy, this represents a major step forward in menopause care.
New HRT Option Nalvee Launched in UK for Menopause Symptom Management
Elinzanetant (Lynkuet): New 52-Week Trial Shows Stronger Evidence — What’s Still Unknown
A year-long study of Elinzanetant (Lynkuet) reveals lasting relief from hot flashes and improved sleep without hormones. Here’s what you need to know about this breakthrough non-hormonal option.
UK Approves First Testosterone Cream for Women: A Milestone in Menopause Care
UK approves first testosterone cream for postmenopausal women—sparking hope for future FDA approval in the U.S.
Elinzanetant Under FDA Review: A Potential New Non-Hormonal Option for Menopausal Symptoms
Elinzanetant (Lynkuet) is a new non-hormonal therapy under FDA review that could finally provide relief from hot flashes for women who can’t or prefer not to take hormone therapy. Promising trial results offer hope for midlife symptom relief.
FDA Panel Reconsiders Black Box Warning on Vaginal Estrogen
For over 20 years, low-dose vaginal estrogen has carried a frightening FDA black box warning—despite no evidence of the risks it lists. Experts now say this outdated label is keeping women from a safe, effective treatment for painful and life-altering menopause symptoms.
New Non-Hormonal Treatment Offers Relief from Menopausal Hot Flashes — With Safety Caveats
Fezolinetant (Veozah) is the first non-hormonal drug approved to tackle menopausal hot flashes—but a rare liver injury warning means careful monitoring is essential. Could this new option finally provide relief for women who can’t or don’t want hormone therapy?
New Research Finds Early Menopause Hormone Therapy May Offer Big Benefits with Lower Risks
A major 2024 review of the Women’s Health Initiative has rewritten the story on hormone therapy. For women under 60 or within 10 years of menopause, the benefits may outweigh the risks—marking a turning point in how doctors and patients approach treatment.
Could a Weekly Pill Delay Menopause? Rapamycin Research Shows Promise
Could a weekly pill shift the menopause timeline? Researchers are exploring how one drug might change the future of women’s health.
New Study Highlights Rising Cardiovascular Risk for Postmenopausal Women
A major study reveals women’s heart health declines rapidly after menopause, making this a crucial time for screening, prevention, and awareness.
The End of Menopause? Scientists Explore Radical New Possibilities
Could menopause one day be optional? Scientists are exploring radical new ways to delay or even prevent it, from ovarian tissue freezing to groundbreaking hormonal research.